Title |
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
|
---|---|
Published in |
bioRxiv, December 2020
|
DOI | 10.1101/2020.12.28.424451 |
Pubmed ID | |
Authors |
Emanuele Andreano, Giulia Piccini, Danilo Licastro, Lorenzo Casalino, Nicole V. Johnson, Ida Paciello, Simeone Dal Monego, Elisa Pantano, Noemi Manganaro, Alessandro Manenti, Rachele Manna, Elisa Casa, Inesa Hyseni, Linda Benincasa, Emanuele Montomoli, Rommie E. Amaro, Jason S. McLellan, Rino Rappuoli |
Abstract |
To investigate the evolution of SARS-CoV-2 in the immune population, we co-incubated authentic virus with a highly neutralizing plasma from a COVID-19 convalescent patient. The plasma fully neutralized the virus for 7 passages, but after 45 days, the deletion of F140 in the spike N-terminal domain (NTD) N3 loop led to partial breakthrough. At day 73, an E484K substitution in the receptor-binding domain (RBD) occurred, followed at day 80 by an insertion in the NTD N5 loop containing a new glycan sequon, which generated a variant completely resistant to plasma neutralization. Computational modeling predicts that the deletion and insertion in loops N3 and N5 prevent binding of neutralizing antibodies. The recent emergence in the United Kingdom and South Africa of natural variants with similar changes suggests that SARS-CoV-2 has the potential to escape an effective immune response and that vaccines and antibodies able to control emerging variants should be developed. Three mutations allowed SARS-CoV-2 to evade the polyclonal antibody response of a highly neutralizing COVID-19 convalescent plasma. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 635 | 20% |
United States | 138 | 4% |
Germany | 89 | 3% |
France | 62 | 2% |
United Kingdom | 43 | 1% |
Spain | 32 | 1% |
Netherlands | 31 | <1% |
Italy | 17 | <1% |
Canada | 17 | <1% |
Other | 179 | 6% |
Unknown | 1937 | 61% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2936 | 92% |
Scientists | 184 | 6% |
Practitioners (doctors, other healthcare professionals) | 44 | 1% |
Science communicators (journalists, bloggers, editors) | 14 | <1% |
Unknown | 2 | <1% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 255 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 55 | 22% |
Student > Ph. D. Student | 37 | 15% |
Student > Bachelor | 28 | 11% |
Student > Master | 21 | 8% |
Student > Doctoral Student | 12 | 5% |
Other | 38 | 15% |
Unknown | 64 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 50 | 20% |
Immunology and Microbiology | 28 | 11% |
Medicine and Dentistry | 28 | 11% |
Agricultural and Biological Sciences | 26 | 10% |
Chemistry | 7 | 3% |
Other | 40 | 16% |
Unknown | 76 | 30% |